Posted by Michael Wonder on 19 Jul 2021
Endologix receives FDA breakthrough device designation for ChEVAS system
19 July 2021 - Investigational EVAS system designed for patients with complex abdominal aortic aneurysm.
Endologix today announced the company’s ChEVAS (Chimney EndoVascular Aneurysm Sealing) System has been granted a breakthrough device designation from the U.S. FDA.
